Citation Impact
Citing Papers
Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
2013
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Breast cancer
2019 Standout
Kinase-targeted cancer therapies: progress, challenges and future directions
2018
Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis
2014
Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension
2013
Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment
2012
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Surgical applications of three-dimensional printing: a review of the current literature & how to get started
2016
2013 European Thyroid Association Guidelines for Cervical Ultrasound Scan and Ultrasound-Guided Techniques in the Postoperative Management of Patients with Thyroid Cancer
2013
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics
2014
Thyroid cancer
2016 Standout
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
2008
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
2008 Standout
Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance
2013
Post-operative neck ultrasound and risk stratification in differentiated thyroid cancer patients with initial lymph node involvement
2014
Optimization of Staging of the Neck With Prophylactic Central and Lateral Neck Dissection for Papillary Thyroid Carcinoma
2012
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
2013
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Differentiated thyroid carcinoma: defining new paradigms for postoperative management
2013
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
2018
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical131I Therapy in Both High- and Low-Risk Patients
2014
Recombinant Human Thyroid-Stimulating Hormone To Stimulate 131-1 Uptake For Remnant Ablation And Adjuvant Therapy
2012
Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective
2009
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
2015
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
2017
Potential Use of Recombinant Human Thyrotropin in the Treatment of Distant Metastases in Patients with Differentiated Thyroid Cancer
2012
Utilidad de la 18F-FDG PET/TC en el cáncer de tiroides
2016
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer
2013
Cancer-associated cachexia
2018 Standout
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
2016
Revisiting the Guidelines Issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: A Gradual Move Towards Consensus Between Japanese and Western Practice in the Management of Thyroid Carcinoma
2014
ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors
2014
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Malignancy Risk Analysis in Patients with Inadequate Fine Needle Aspiration Cytology (FNAC) of the Thyroid
2012
Progress in molecular-based management of differentiated thyroid cancer
2013
Targeting apoptosis in cancer therapy
2020 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Dosimetry and thyroid cancer: the individual dosage of radioiodine
2010
Stimulation of Erythrocyte Cell Membrane Scrambling by Amiodarone
2007
Liquid biopsy
2015
How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma?
2013
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
2017 Standout
Sarcopenia
2019 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Analysis of anticancer drugs: A review
2011 Standout
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
2014
Precision medicine in NSCLC and pathology: how does ALK fit in the pathway?
2016
Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
2015
Radioactive iodine therapy
2012
Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH
2009
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit
2009
The PI3K Pathway in Human Disease
2017 Standout
Advances in the follow-up of differentiated or medullary thyroid cancer
2012
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
2019
rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer
2013
Management of advanced medullary thyroid cancer
2015
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Artificial intelligence in radiology
2018 Standout
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
2016
Update on Differentiated Thyroid Cancer Staging
2014
Current management of pediatric thyroid disease and differentiated thyroid cancer
2015
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
The Role of Recombinant Human Thyrotropin for Diagnostic Monitoring of Patients with Differentiated Thyroid Cancer
2013
Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma
2013
High versus low radioiodine activity in patients with differentiated thyroid cancer: A meta-analysis
2012
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
The 2017 Bethesda System for Reporting Thyroid Cytopathology
2017 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Postoperative Stimulated Thyroglobulin of Less Than 1 ng/mL as a Criterion to Spare Low-Risk Patients with Papillary Thyroid Cancer from Radioactive Iodine Ablation
2012
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal
2013
Quality of Life in Patients with Thyroid Cancer Compared with the General Population
2011
Diagnostic Value and Cost Considerations of Routine Fine-Needle Aspirations in the Follow-Up of Thyroid Nodules with Benign Readings
2010
Is Empirical Radioactive Iodine Therapy Still a Valid Approach to Patients with Thyroid Cancer and Elevated Thyroglobulin?
2013
Radioiodine Treatment of Metastatic Thyroid Cancer: Relative Efficacy and Side Effect Profile of Preparation by Thyroid Hormone Withdrawal Versus Recombinant Human Thyrotropin
2012
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Long-Term Results after Treatment of Very Low-, Low-, and High-Risk Thyroid Cancers in a Combined Setting of Thyroidectomy and Radio Ablation Therapy in Euthyroidism
2013
Obesity and Cancer Mechanisms: Cancer Metabolism
2016
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Screening for Thyroid Cancer
2017
Hyaluronic acid-functionalized electrospun PLGA nanofibers embedded in a microfluidic chip for cancer cell capture and culture
2017
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Undetectable Sensitive Serum Thyroglobulin (<0.1 ng/ml) in 163 Patients with Follicular Cell-Derived Thyroid Cancer: Results of rhTSH Stimulation and Neck Ultrasonography and Long-Term Biochemical and Clinical Follow-Up
2012
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
Update in Adrenocortical Carcinoma
2013
Application of Computer-Aided Diagnosis to the Sonographic Evaluation of Cervical Lymph Nodes
2015
The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
2014
Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses.
2013
Rapid on‐site assessment of specimens by biomedical scientists improves the quality of head and neck fine needle aspiration cytology
2013
Can we interpret serum thyroglobulin results?
2012
Recombinant Thyrotropin Use in Children and Adolescents with Differentiated Thyroid Cancer: A Multicenter Retrospective Study
2009
Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma
2013
Screening for Colorectal Cancer
2016 Standout
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
2013
The Utility of Serum Thyroglobulin Measurement at the Time of Remnant Ablation for Predicting Disease-Free Status in Patients with Differentiated Thyroid Cancer: A Meta-Analysis Involving 3947 Patients
2012
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
2010
A simplified economic approach to thyroid FNA cytology and surgical intervention in thyroid nodules
2013
FDM process parameters influence over the mechanical properties of polymer specimens: A review
2018 Standout
Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-Analysis
2013
Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal
2009
Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step
2010
Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
2012
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
BRAFV600E Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in aBRAFV600E-Prevalent Population
2010
Ultrasound-Guided Fine Needle Aspiration of Thyroid Nodules: A Consensus Statement by the Korean Society of Thyroid Radiology
2015
Cancer treatment and survivorship statistics, 2019
2019 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Stimulation of Erythrocyte Cell Membrane Scrambling by Nystatin
2014
Guidelines for the management of thyroid cancer
2014 Standout
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
A Novel Mass Spectrometry–Based Assay for the Accurate Measurement of Thyroglobulin from Patient Samples Containing Antithyroglobulin Autoantibodies
2012
No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
2014
Erythropoietin or darbepoetin for patients with cancer
2012
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy
2011
Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus
2013
Iodine Biokinetics and Radioiodine Exposure after Recombinant Human Thyrotropin-Assisted Remnant Ablation in Comparison with Thyroid Hormone Withdrawal
2010
Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?
2015
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
2012
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Isabelle Borget being referenced
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK -Rearranged Non–Small Cell Lung Cancer Patients
2017
Influence of Prophylactic Neck Dissection on Rate of Retreatment for Papillary Thyroid Carcinoma
2013
131 I Effective Half-Life and Dosimetry in Thyroid Cancer Patients
2008
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up
2011
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
2012
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
2013
Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review
2016
Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
2011
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
2010
Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?
2011
Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen
2008
Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients
2011
Assessment of the Cost of Fine-Needle Aspiration Cytology as a Diagnostic Tool in Patients With Thyroid Nodules
2008
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer
2015
Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal
2007
Evaluation of the Accuracy of a Computer-aided Diagnosis (CAD) System in Breast Ultrasound according to the Radiologist’s Experience
2012
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation
2013
Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy
2006
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
2014
Treatment and follow-up of low-risk patients with thyroid cancer
2011
Vandetanib for the Treatment of Advanced Medullary Thyroid Cancer Outside a Clinical Trial: Results from a French Cohort
2015
Postradioiodine Treatment Whole-Body Scan in the Era of 18-Fluorodeoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with Elevated Serum Thyroglobulin Levels
2012
Postoperative Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: An Important Imaging Modality in Patients with Aggressive Histology of Differentiated Thyroid Cancer
2015
[Cost-effectiveness of darbepoetin alpha in an every-3-weeks schedule].
2008
Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study
2013
Prognostic factors of advanced unresectable by stage III and IV ENS@T adrenocortical carcinomas (ACC)
2013
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer
2013